EDGAR Filing Documents for 0001640334-22-000556

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001640334-22-000556

Filing Date

2022-03-22

Accepted

2022-03-22 14:56:10

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	nymox_424b5.htm	424B5	114496
2		nymox_424b5img1.jpg	GRAPHIC	2968
	Complete submission text file	0001640334-22-000556.txt		119726

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261571 | Film No.: 22759013
SIC: 2835 In Vitro & In Vivo Diagnostic Substances